Construction and Characterization of Infectious Molecular Clones of HIV-1 CRF63_02A6

Daria P Zyryanova1, Alexei V Totmenin1, Natalia V Bogacheva1

  • 1Department of Retroviruses, State Research Center of Virology and Biotechnology "Vector", Koltsovo, Russia.

Insights

Researchers constructed infectious molecular clones of the prevalent HIV-1 CRF63_02A6 variant circulating in Siberia. These well-characterized clones facilitate further study of this significant HIV subtype.

Area of Science:

  • Virology
  • Genetics
  • Molecular Biology

Background:

  • The HIV-1 CRF63_02A6 subtype is the predominant genetic variant among HIV-infected individuals in the Siberian Federal District, Russia.
  • Understanding the characteristics of prevalent HIV strains is crucial for developing effective treatment and prevention strategies.

Purpose of the Study:

  • To construct and characterize infectious molecular clones (IMCs) of the HIV-1 CRF63_02A6 subtype.
  • To provide tools for basic and applied research on this prevalent Russian HIV-1 variant.

Main Methods:

  • Construction of near full-length proviral HIV-1 sequences (pT11.17 and pMtBs.18) from 2015 and 2017 isolates.
  • Production of IMC virions via HEK293T cell transfection and assessment of viral growth in peripheral blood mononuclear cell cultures.
  • Determination of viral tropism using genotypic (Geno2pheno) and phenotypic assays in MT-2, U87-CD4-CCR5, and U87-CD4-CXCR4 cell lines.

Main Results:

  • Stable replication of CRF63_02A6 IMCs was achieved, with significant increases in p24 concentration and viral protein accumulation.
  • Genotypic and phenotypic analyses confirmed the R5-tropic and X4-tropic nature of the constructed IMCs.
  • The generated IMCs represent viable tools for studying HIV-1 CRF63_02A6.

Conclusions:

  • Successfully constructed and characterized R5-tropic and X4-tropic HIV-1 CRF63_02A6 infectious molecular clones.
  • These IMCs are stable and replicate efficiently in cell culture, validating their utility.
  • The developed IMCs offer valuable resources for advancing research on HIV-1 CRF63_02A6 in Russia and beyond.

Related Concept Videos

Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone07:35

Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone

This protocol describes the recovery of infectious Zika virus from a two-plasmid infectious cDNA...
10.1K
Visualizing Cell-to-cell Transfer of HIV using Fluorescent Clones of HIV and Live Confocal Microscopy13:08

Visualizing Cell-to-cell Transfer of HIV using Fluorescent Clones of HIV and Live Confocal Microscopy

This visualized experiment is a guide for utilizing a fluorescent molecular clone of HIV for live confocal imaging...
17.0K
SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells10:24

SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells

Here, we describe a quantitative proteomics method using the technique of stable isotope labeling by amino acids in cell culture (SILAC) to analyze the effects of HIV-1 infection on host exosomal proteomes. This protocol can be easily adapted to cells under different stress or infection...
11.1K
Molecular Cloning09:55

Molecular Cloning

Molecular cloning is a set of methods, which are used to insert recombinant DNA into a vector - a carrier of DNA molecules that will replicate recombinant DNA fragments in host organisms. The DNA fragment, which may be a gene, can be isolated from a prokaryotic or eukaryotic specimen. Following isolation of the fragment of interest, or insert, both the vector and insert must be cut with restriction enzymes and purified. The purified pieces are joined together though a technique called...
389.8K
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

HIV-1 pathogenesis is defined by both viral characteristics and host genetic factors. Here we describe a robust method that allows for reproducible measurements to assess the impact of the gag gene sequence variation on the in vitro replication capacity of the...
16.1K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Quantifying levels of HIV-1 RNA in plasma and sequencing single HIV-1 genomes from individuals with viral loads below the limit of detection (50-75 copies/ml) is difficult. Here we describe how to extract and quantify plasma viral RNA using a real time PCR assay that reliably measures HIV-1 RNA down to 0.3 copies/ml and how to amplify viral genomes by single genome sequencing, from samples with very low viral...
32.1K